Finance

Lists
PALI:NASDAQ
Palisade Bio Inc
၁.၁၃ US$
၀.၀၀%
(၀.၀၀) 1D
၁.၁၂ US$
-၀.၆၈% (-၀.၀၀၇၇)
Pre-market
Closed: နို ၁၀, GMT-၅ ၁၆:၀၀:၀၁  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PALI...
Mkt. cap
၁၉.၆၉ ကုဋေ
Avg. vol.
၃.၃၄ သန်း
Volume
၅.၁၈ ထောင်
52-wk high
၂.၈၆ US$
52-wk low
၁.၀၈ US$
EPS
-၀.၆၄ US$
Beta
၁.၆၁
Shares outstanding
၁၇.၄၃ ကုဋေ
No. of employees
၁၄
Mkt. cap
၁၉.၆၉ ကုဋေ
Avg. vol.
၃.၃၄ သန်း
Volume
၅.၁၈ ထောင်
52-wk high
၂.၈၆ US$
52-wk low
၁.၀၈ US$
EPS
-၀.၆၄ US$
Beta
၁.၆၁
Shares outstanding
၁၇.၄၃ ကုဋေ
No. of employees
၁၄
News stories
From web sources and news partners
GuruFocus
GuruFocus
·
ပြီးခဲ့သည့် ၈ နာရီ
Palisade Bio (PALI) Reports Q3 Earnings Miss, Market Pricing Reflects Growth Uncertainty
Investing.com
Investing.com
·
ပြီးခဲ့သည့် ၁၅ နာရီ
Palisade Bio doses first patient in ulcerative colitis trial
About Palisade Bio Inc
CEO-
Employees၁၄
Founded၂၀၀၅
Headquartersကားလ်စ်ဘတ်, ကယ်လီဖိုးနီးယားပြည်နယ်, ယူနိုက်တက်စတိတ်
SectorHealth Care
Industry-
Analyst ratings
Based on 6 analysts giving stock ratings to PALI in the past 3 months
Strong buy
Buy
6
Hold
0
Sell
0
12-month forecast
Based on 6 Wall Street analysts offering 12 month price targets for PALI in the last 3 months.
Highest
Current ၁.၁၃ US$
၂၅.၀၀ US$ (+၂,၁၁၂.၃၉%)
Average
၉.၈၃ US$ (+၇၆၉.၉၁%)
Lowest
၅.၀၀ US$ (+၃၄၂.၄၈%)
Analyst
Recommendation
Action
Price target
Projected
Date
Mitchell Kapoor
H.C. Wainwright
Buy
Reiterated
၅.၀၀ US$
+၃၄၂.၅%
11/11/2026
Leland Gershell
Oppenheimer
Buy
Maintained
၈.၀၀ US$
+၆၀၈%
10/21/2026
Thomas Deal
Raymond James
Buy
Initiated
၆.၀၀ US$
+၄၃၁%
10/08/2026
Unknown Analyst
Raymond James
Buy
Initiated
၆.၀၀ US$
+၄၃၁%
10/08/2026
Yasmeen Rahimi
Piper Sandler
Buy
Maintained
၂၅.၀၀ US$
+၂,၁၁၂.၄%
09/23/2026
Naz Rahman
Maxim Group
Buy
Reiterated
၈.၀၀ US$
+၆၀၈%
08/12/2026
Unknown Analyst
B. Riley Securities
Buy
Initiated
၇.၀၀ US$
+၅၁၉.၅%
08/12/2026
Alex Thompson CFA
Stifel Nicolaus
Buy
Maintained
၅.၀၀ US$
+၃၄၂.၅%
07/06/2026
William Wood
B. Riley Securities
Buy
Reiterated
၇.၀၀ US$
+၅၁၉.၅%
06/02/2026
Andy Chen
Wolfe Research
Buy
Initiated
၇.၀၀ US$
+၅၁၉.၅%
04/08/2026
Kaveri Pohlman
Clear Street
Buy
Maintained
၁၂.၀၀ US$
+၉၆၁.၉%
03/31/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
၂၀၂၆ ဇွန်
Revenue
-
-
-
၅.၀၀ သိန်း
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
၁.၃၉ သန်း
၆.၁၇ သန်း
၆.၄၀ သန်း
၇.၄၀ သန်း
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၁.၅၃ သန်း
၃.၈၁ သန်း
၄.၃၅ သန်း
၄.၈၀ သန်း
Operating expense
၂.၉၂ သန်း
၉.၉၈ သန်း
၁.၀၇ ကုဋေ
၁.၂၂ ကုဋေ
Total operating expenses
၂.၉၂ သန်း
၉.၉၈ သန်း
၁.၀၇ ကုဋေ
၁.၂၂ ကုဋေ
Operating income
-၂.၉၂ သန်း
-၉.၉၈ သန်း
-၁.၀၇ ကုဋေ
-၁.၁၇ ကုဋေ
Other non operating income
၅.၉၀ သောင်း
၁.၀၈ သန်း
၁.၁၅ သန်း
၁.၁၂ သန်း
EBT including unusual items
-၂.၈၇ သန်း
-၈.၉၀ သန်း
-၉.၆၀ သန်း
-၁.၀၆ ကုဋေ
EBT excluding unusual items
-၂.၈၇ သန်း
-၈.၉၀ သန်း
-၉.၆၀ သန်း
-၁.၀၆ ကုဋေ
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-၂.၈၇ သန်း
-၈.၉၀ သန်း
-၉.၆၀ သန်း
-၁.၀၆ ကုဋေ
Net profit margin
-
-
-
-၂,၁၁၄.၈၀%
Earnings per share
-၀.၃၈
-
-၀.၀၅
-၀.၀၅
Interest and investment income
-
-
-
-
Interest expense
-၅.၀၀ ထောင်
-၂.၀၀ ထောင်
-၁.၀၀ ထောင်
-
Net interest expenses
-၅.၀၀ ထောင်
-၂.၀၀ ထောင်
-၁.၀၀ ထောင်
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-၂.၉၂ သန်း
-၉.၉၈ သန်း
-၁.၀၇ ကုဋေ
-၁.၁၇ ကုဋေ
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google အက်ပ်များ